Divergence Watchlist – 11/06/2017

Here we go!

We have a big week ahead so let’s get right down to business.

Divergence Watchlist 11/06/2017: IMMU, ANDX, BB, CLVS, SGMO, LABU, NFLX

IMMU Divergence Chart 11052017
Immunomedics (IMMU) has set up for us once again. This is a nice divergence setup where you can see clear lower lows in the price and clear higher lows in the stochastic . Wait for a break above the recent highs and get in at/above 11.40.
Buy: 11.40
Target: 11.64 – 12.18 (2.11% – 6.84%)
ANDX Divergence Chart 110517
Andeavor Logistics (ANDX) has stochastic divergence and is converging with trend line support in a descending channel.
Buy: 45.25
Target: 46.19 – 48.03 (2.08% – 6.14%)
BB Divergence Chart 110517
BlackBerry (BB) has formed a cup and handle pattern with stochastic divergence.
Buy: 11.20
CLVS Divergence Chart 110517
Clovis Oncology (CLVS) has stochastic divergence at trend line support of an ascending channel. Looking to bounce back up in the channel.
Buy: 74.11
Target: 76.43 – 80.40 (3.13% – 8.49%)
SGMO Divergence Chart 110517
Sangamo Theraputics (SGMO) has stochastic divergence on channel line support. Look for this to turn up more before getting in.
Buy: 12.66
Target: 13.50 – 14.86 (6.64% – 17.38%)
LABU Chart 110517
Direxion Daily S&P Biotech Bull 3X ETF (LABU) is on the channel line with stochastic divergence.  Divergences have reacted well and I expect this one to pop a little more. Not posting a trade, I just like the sector this week.
NFLX Chart 110517
Netflix (NFLX) is bullish. The hourly has multiple divergences. This is a buy at 201.10

Also watching: ERX, ILMN, WDC, PCAR, TSRO, WES, MIC, CONE, AKCA


Check out last week’s Divergence Watchlist.

Follow me on Twitter.

Or Follow me on StockTwits.

Follow me on TradingView and view live charts.


Trading involves substantial risk of loss and is not suitable for all investors. Past performance is not indicative of future results. Opinions, market data, and recommendations are subject to change at any time. It is important to do your own research and analysis before entering a trade. Any trade you make is at your own risk.